immune cell infiltration and immune-related genes in the tumor microenvironment

mutationdetection

The impact of chromosomal fusions on 3D genome folding and recombination in the germ line

The spatial folding of chromosomes inside the nucleus has regulatory effects on gene expression, yet the impact of genome reshuffling on this organization remains unclear. Here, we take advantage of chromosome conformation capture in combination with single-nucleotide polymorphism (SNP) genotyping and analysis of crossover events to study how the higher-order chromatin organization and recombination landscapes are affected by chromosomal fusions in the mammalian germ line.

We demonstrate that chromosomal fusions alter the nuclear architecture during meiosis, including an increased rate of heterologous interactions in primary spermatocytes, and alterations in both chromosome synapsis and axis length.

These disturbances in topology were associated with changes in genomic landscapes of recombination, resulting in detectable genomic footprints. Overall, we show that chromosomal fusions impact the dynamic genome topology of germ cells in two ways: (i) altering chromosomal nuclear occupancy and synapsis, and (ii) reshaping landscapes of recombination.

Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of HNSCC with or without HPV infection

Head and neck squamous cell carcinoma (HNSCC) are the sixth most common cancer type in the world. Human papillomavirus (HPV) infection is an emerging risk factor for HNSCC. Immune infiltration of HNSCC is linked to therapeutic results. This article aimed to decide whether variations in HPV status affect immune infiltration, molecular mechanism, and how these results vary in HNSCC patients.

We investigated the tumor-infiltrating immune cells (TIICs) and immune-related gene differences between HPV (+) and HPV (-) HNSCC. The gene expression quantification data of HNSCC and their clinical information were download from the TCGA database. Immune-related genes have been linked to the ImmPort platform.

After analyzed of 22 TIICs in the HNSCC tumor environment by CIBERSORT and further assessment, lower memory B cell and higher T cell regulatory were connected with better HPV (-) HNSCC outcome, higher activated memory CD4 T cell, higher T cell regulatory, and lower activated NK cell were linked with better HPV (+) result.

We finally got five forms of immune genes (CAMP, EDNRB, NTS, CXCL9, LHB) associated with HNSCC progression. Higher expressions of CAMP, EDNRB, and NTS were associated with increased overall survival in HPV (-) patients. Higher expression of CXCL9 and lower expression of LHB contributed to increased overall survival of HPV (+) patients.

There tend to be discrepancies in the cell structure of TIICs and immune-related genes in HPV (-) and HPV (+) HNSCC. These variances are typically too crucial for the therapeutic outcome of the patient and the development of the tumor. In specific, our sample established these candidate immune cells and immune-related genes as candidate reservoirs for further researches.

mutationdetection
mutationdetection

TAO Kinase inhibitor 1

T16987-1mg 1mg Ask for price
Description: TAO Kinase inhibitor 1

TAO Kinase inhibitor 1

T16987-50mg 50mg Ask for price
Description: TAO Kinase inhibitor 1

TAO Kinase inhibitor 1

T16987-5mg 5mg Ask for price
Description: TAO Kinase inhibitor 1

TAO Kinase inhibitor 1

HY-112136 50mg
EUR 955.2

Tpl2 Kinase Inhibitor 1

T17145-10mg 10mg Ask for price
Description: Tpl2 Kinase Inhibitor 1

Tpl2 Kinase Inhibitor 1

T17145-1g 1g Ask for price
Description: Tpl2 Kinase Inhibitor 1

Tpl2 Kinase Inhibitor 1

T17145-1mg 1mg Ask for price
Description: Tpl2 Kinase Inhibitor 1

Tpl2 Kinase Inhibitor 1

T17145-50mg 50mg Ask for price
Description: Tpl2 Kinase Inhibitor 1

Tpl2 Kinase Inhibitor 1

T17145-5mg 5mg Ask for price
Description: Tpl2 Kinase Inhibitor 1

EGFR kinase inhibitor 1

T63648-10mg 10mg Ask for price
Description: EGFR kinase inhibitor 1

EGFR kinase inhibitor 1

T63648-1g 1g Ask for price
Description: EGFR kinase inhibitor 1

EGFR kinase inhibitor 1

T63648-1mg 1mg Ask for price
Description: EGFR kinase inhibitor 1

EGFR kinase inhibitor 1

T63648-50mg 50mg Ask for price
Description: EGFR kinase inhibitor 1

EGFR kinase inhibitor 1

T63648-5mg 5mg Ask for price
Description: EGFR kinase inhibitor 1

Tie2 kinase inhibitor 1

T6335-10mg 10mg Ask for price
Description: Tie2 kinase inhibitor 1

Tie2 kinase inhibitor 1

T6335-1g 1g Ask for price
Description: Tie2 kinase inhibitor 1

Tie2 kinase inhibitor 1

T6335-1mg 1mg Ask for price
Description: Tie2 kinase inhibitor 1

Tie2 kinase inhibitor 1

T6335-50mg 50mg Ask for price
Description: Tie2 kinase inhibitor 1

Tie2 kinase inhibitor 1

T6335-5mg 5mg Ask for price
Description: Tie2 kinase inhibitor 1

RIP1 kinase inhibitor 1

T12725-10mg 10mg Ask for price
Description: RIP1 kinase inhibitor 1

RIP1 kinase inhibitor 1

T12725-1g 1g Ask for price
Description: RIP1 kinase inhibitor 1

RIP1 kinase inhibitor 1

T12725-1mg 1mg Ask for price
Description: RIP1 kinase inhibitor 1

RIP1 kinase inhibitor 1

T12725-50mg 50mg Ask for price
Description: RIP1 kinase inhibitor 1

RIP1 kinase inhibitor 1

T12725-5mg 5mg Ask for price
Description: RIP1 kinase inhibitor 1

RIP2 kinase inhibitor 1

T12727-10mg 10mg Ask for price
Description: RIP2 kinase inhibitor 1

RIP2 kinase inhibitor 1

T12727-1g 1g Ask for price
Description: RIP2 kinase inhibitor 1

RIP2 kinase inhibitor 1

T12727-1mg 1mg Ask for price
Description: RIP2 kinase inhibitor 1

RIP2 kinase inhibitor 1

T12727-50mg 50mg Ask for price
Description: RIP2 kinase inhibitor 1

RIP2 kinase inhibitor 1

T12727-5mg 5mg Ask for price
Description: RIP2 kinase inhibitor 1

Pim-1 kinase inhibitor 1

T60972-10mg 10mg Ask for price
Description: Pim-1 kinase inhibitor 1

Pim-1 kinase inhibitor 1

T60972-1g 1g Ask for price
Description: Pim-1 kinase inhibitor 1

Pim-1 kinase inhibitor 1

T60972-1mg 1mg Ask for price
Description: Pim-1 kinase inhibitor 1

Pim-1 kinase inhibitor 1

T60972-50mg 50mg Ask for price
Description: Pim-1 kinase inhibitor 1

Pim-1 kinase inhibitor 1

T60972-5mg 5mg Ask for price
Description: Pim-1 kinase inhibitor 1

PDGFRα kinase inhibitor 1

T12396-10mg 10mg Ask for price
Description: PDGFRα kinase inhibitor 1

PDGFRα kinase inhibitor 1

T12396-1g 1g Ask for price
Description: PDGFRα kinase inhibitor 1

PDGFRα kinase inhibitor 1

T12396-1mg 1mg Ask for price
Description: PDGFRα kinase inhibitor 1

PDGFRα kinase inhibitor 1

T12396-50mg 50mg Ask for price
Description: PDGFRα kinase inhibitor 1

PDGFRα kinase inhibitor 1

T12396-5mg 5mg Ask for price
Description: PDGFRα kinase inhibitor 1

Pim-1 kinase inhibitor 2

T62001-10mg 10mg Ask for price
Description: Pim-1 kinase inhibitor 2

Pim-1 kinase inhibitor 2

T62001-1g 1g Ask for price
Description: Pim-1 kinase inhibitor 2

Pim-1 kinase inhibitor 2

T62001-1mg 1mg Ask for price
Description: Pim-1 kinase inhibitor 2

Pim-1 kinase inhibitor 2

T62001-50mg 50mg Ask for price
Description: Pim-1 kinase inhibitor 2

Pim-1 kinase inhibitor 2

T62001-5mg 5mg Ask for price
Description: Pim-1 kinase inhibitor 2

Pim-1 kinase inhibitor 3

T61074-10mg 10mg Ask for price
Description: Pim-1 kinase inhibitor 3

Pim-1 kinase inhibitor 3

T61074-1g 1g Ask for price
Description: Pim-1 kinase inhibitor 3

Pim-1 kinase inhibitor 3

T61074-1mg 1mg Ask for price
Description: Pim-1 kinase inhibitor 3

Pim-1 kinase inhibitor 3

T61074-50mg 50mg Ask for price
Description: Pim-1 kinase inhibitor 3

Pim-1 kinase inhibitor 3

T61074-5mg 5mg Ask for price
Description: Pim-1 kinase inhibitor 3

Pim-1/2 kinase inhibitor 1

T9229-10mg 10mg Ask for price
Description: Pim-1/2 kinase inhibitor 1

Pim-1/2 kinase inhibitor 1

T9229-1g 1g Ask for price
Description: Pim-1/2 kinase inhibitor 1

Pim-1/2 kinase inhibitor 1

T9229-1mg 1mg Ask for price
Description: Pim-1/2 kinase inhibitor 1

Pim-1/2 kinase inhibitor 1

T9229-50mg 50mg Ask for price
Description: Pim-1/2 kinase inhibitor 1

Pim-1/2 kinase inhibitor 1

T9229-5mg 5mg Ask for price
Description: Pim-1/2 kinase inhibitor 1

Pan-RAF kinase inhibitor 1

T63386-10mg 10mg Ask for price
Description: Pan-RAF kinase inhibitor 1

Pan-RAF kinase inhibitor 1

T63386-1g 1g Ask for price
Description: Pan-RAF kinase inhibitor 1

Pan-RAF kinase inhibitor 1

T63386-1mg 1mg Ask for price
Description: Pan-RAF kinase inhibitor 1

Pan-RAF kinase inhibitor 1

T63386-50mg 50mg Ask for price
Description: Pan-RAF kinase inhibitor 1

Pan-RAF kinase inhibitor 1

T63386-5mg 5mg Ask for price
Description: Pan-RAF kinase inhibitor 1

Protein kinase D inhibitor 1

T61163-10mg 10mg Ask for price
Description: Protein kinase D inhibitor 1

Protein kinase D inhibitor 1

T61163-1g 1g Ask for price
Description: Protein kinase D inhibitor 1

Protein kinase D inhibitor 1

T61163-1mg 1mg Ask for price
Description: Protein kinase D inhibitor 1

Protein kinase D inhibitor 1

T61163-50mg 50mg Ask for price
Description: Protein kinase D inhibitor 1

Protein kinase D inhibitor 1

T61163-5mg 5mg Ask for price
Description: Protein kinase D inhibitor 1

EML4-ALK kinase inhibitor 1

T11184-10mg 10mg Ask for price
Description: EML4-ALK kinase inhibitor 1

EML4-ALK kinase inhibitor 1

T11184-1g 1g Ask for price
Description: EML4-ALK kinase inhibitor 1

EML4-ALK kinase inhibitor 1

T11184-1mg 1mg Ask for price
Description: EML4-ALK kinase inhibitor 1

EML4-ALK kinase inhibitor 1

T11184-50mg 50mg Ask for price
Description: EML4-ALK kinase inhibitor 1

EML4-ALK kinase inhibitor 1

T11184-5mg 5mg Ask for price
Description: EML4-ALK kinase inhibitor 1

AKT Kinase Inhibitor

A3150-10 10 mg
EUR 1363.2
Description: AKT Kinase Inhibitor

AKT Kinase Inhibitor

A3150-5 5 mg
EUR 819.6
Description: AKT Kinase Inhibitor

AKT Kinase Inhibitor

A3150-5.1 10 mM (in 1mL DMSO)
EUR 895.2
Description: AKT Kinase Inhibitor

AKT Kinase Inhibitor

HY-10249A 10mg
EUR 1052.4

AKT Kinase Inhibitor

T10276-10mg 10mg Ask for price
Description: AKT Kinase Inhibitor

AKT Kinase Inhibitor

T10276-1g 1g Ask for price
Description: AKT Kinase Inhibitor

AKT Kinase Inhibitor

T10276-1mg 1mg Ask for price
Description: AKT Kinase Inhibitor

AKT Kinase Inhibitor

T10276-50mg 50mg Ask for price
Description: AKT Kinase Inhibitor

AKT Kinase Inhibitor

T10276-5mg 5mg Ask for price
Description: AKT Kinase Inhibitor

Tie2 kinase inhibitor

E1KS1577 10mg
EUR 1147.2

Tie2 Kinase Inhibitor

B1338-25 each
EUR 907.2

Tie2 Kinase Inhibitor

B1338-5 each
EUR 314.4

Tie2 kinase inhibitor

A5979-100 100 mg
EUR 800
Description: Tie-2(Tie2 ) inhibitor

Tie2 kinase inhibitor

A5979-25 25 mg
EUR 240
Description: Tie-2(Tie2 ) inhibitor

Tie2 kinase inhibitor

A5979-5 5 mg
EUR 80
Description: Tie-2(Tie2 ) inhibitor

Tie2 kinase inhibitor

A5979-5.1 10 mM (in 1mL DMSO)
EUR 274
Description: Tie-2(Tie2 ) inhibitor

Cyclin-dependent kinase inhibitor 1 Cyclin-dependent kinase inhibitor 1A (cip1) Antibody

abx345851-100l 100 µl
EUR 350

Cyclin-dependent kinase inhibitor 1 Cyclin-dependent kinase inhibitor 1A (cip1) Antibody

abx345851-50l 50 µl
EUR 250

MAPKII Kinase Inhibitor

abx076811-1mg 1 mg
EUR 376.8

MAPKII Kinase Inhibitor

SIH-120A 1 mg
EUR 114
Description: Hsp25 Kinase Inhibitor

MAPKII Kinase Inhibitor

abx076811-100l 100 µl
EUR 337.5

MAPKII Kinase Inhibitor

abx076811-1ml 1 ml Ask for price

MAPKII Kinase Inhibitor

abx076811-200l 200 µl Ask for price

Tyrosine kinase inhibitor

T17184-10mg 10mg Ask for price
Description: Tyrosine kinase inhibitor

Tyrosine kinase inhibitor

T17184-1g 1g Ask for price
Description: Tyrosine kinase inhibitor

Tyrosine kinase inhibitor

T17184-1mg 1mg Ask for price
Description: Tyrosine kinase inhibitor

Tyrosine kinase inhibitor

T17184-50mg 50mg Ask for price
Description: Tyrosine kinase inhibitor

Tyrosine kinase inhibitor

T17184-5mg 5mg Ask for price
Description: Tyrosine kinase inhibitor

Tyrosine kinase inhibitor

HY-10421 25mg
EUR 459.6

Cyclin-dependent kinase inhibitor 1

AP81438 1mg
EUR 2640

Cyclin-dependent kinase inhibitor 1

AP81644 1mg
EUR 2640

Aurora kinase inhibitor-10

T63853-10mg 10mg Ask for price
Description: Aurora kinase inhibitor-10

Aurora kinase inhibitor-10

T63853-1g 1g Ask for price
Description: Aurora kinase inhibitor-10

Aurora kinase inhibitor-10

T63853-1mg 1mg Ask for price
Description: Aurora kinase inhibitor-10

Aurora kinase inhibitor-10

T63853-50mg 50mg Ask for price
Description: Aurora kinase inhibitor-10

Aurora kinase inhibitor-10

T63853-5mg 5mg Ask for price
Description: Aurora kinase inhibitor-10

IKK-? Kinase Inhibitor II

1811-1 each
EUR 189.6

IKK-? Kinase Inhibitor II

1811-5 each
EUR 574.8

Aurora kinase inhibitor-8

T63773-10mg 10mg Ask for price
Description: Aurora kinase inhibitor-8

Aurora kinase inhibitor-8

T63773-1g 1g Ask for price
Description: Aurora kinase inhibitor-8

Aurora kinase inhibitor-8

T63773-1mg 1mg Ask for price
Description: Aurora kinase inhibitor-8

Aurora kinase inhibitor-8

T63773-50mg 50mg Ask for price
Description: Aurora kinase inhibitor-8

Aurora kinase inhibitor-8

T63773-5mg 5mg Ask for price
Description: Aurora kinase inhibitor-8

Aurora kinase inhibitor-9

T62789-10mg 10mg Ask for price
Description: Aurora kinase inhibitor-9

Aurora kinase inhibitor-9

T62789-1g 1g Ask for price
Description: Aurora kinase inhibitor-9

Aurora kinase inhibitor-9

T62789-1mg 1mg Ask for price
Description: Aurora kinase inhibitor-9

Aurora kinase inhibitor-9

T62789-50mg 50mg Ask for price
Description: Aurora kinase inhibitor-9

Aurora kinase inhibitor-9

T62789-5mg 5mg Ask for price
Description: Aurora kinase inhibitor-9

Aurora kinase inhibitor-2

T9040-10mg 10mg Ask for price
Description: Aurora kinase inhibitor-2

Aurora kinase inhibitor-2

T9040-1g 1g Ask for price
Description: Aurora kinase inhibitor-2

Aurora kinase inhibitor-2

T9040-1mg 1mg Ask for price
Description: Aurora kinase inhibitor-2

Multi-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage

The evolutionary pressure of endemic malaria and other erythrocytic pathogens has shaped variation in genes encoding erythrocyte structural and functional proteins, influencing responses to hemolytic stress during transfusion and disease.

We sought to identify such genetic variants in blood donors by conducting a genome-wide association study (GWAS) of 12,353 volunteer donors, including 1,483 African Americans, 1,477 Asians, and 960 Hispanics, whose stored erythrocytes were characterized by quantitative assays of in vitro osmotic, oxidative, and cold-storage hemolysis.

GWAS revealed 27 significant loci (p<5×10-8), many in candidate genes known to modulate erythrocyte structure, metabolism, and ion channels, including SPTA1, ALDH2, ANK1, HK1, MAPKAPK5, AQP1, PIEZO1, and SLC4A1/Band 3. GWAS of oxidative hemolysis identified variants in antioxidant enzymes including GLRX, GPX4, G6PD, and a novel golgi-transport protein SEC14L4.

Genome wide significant loci were also tested for association with the severity of steady state (baseline) in vivo hemolytic anemia in patients with sickle cell disease, with confirmation of identified SNPs in HBA2, G6PD, PIEZO1, AQP1 and SEC14L4. Many of the identified variants, such as those in G6PD, have previously been shown to impair erythrocyte recovery after transfusion, associate with anemia, or cause rare Mendelian human hemolytic diseases.

Candidate SNPs in these genes, especially in polygenic combinations, may affect RBC recovery after transfusion and modulate disease severity in hemolytic diseases, such as sickle cell disease and malaria.

Incorporating Genomic and Genetic Testing into the Treatment of Metastatic Luminal Breast Cancer

Background: Treatment of patients with luminal metastatic breast cancer (MBC) has become even more complex over the last few years as molecular profiling has begun to alter disease management. It is well accepted that MBC is not curable but is treatable. Today we are able to prolong progression-free survival and partly overall survival with targeted and more individual treatment strategies adjusted according to the molecular subtype.

Summary: Genetic and genomic testing has become therapeutically relevant in luminal MBC and is therefore an integral component within the treatment spectrum. By now, germline testing of BRCABRCAPIK3CA mutations are inevitable elements in disease management and the current state of the art in luminal MBC patients.

Furthermore, testing of ESR1 resistance mutation, ERBB2 mutation, microsatellite instability, and neurotrophic tyrosine receptor kinase (NTRK) gene fusion (mainly in secretory breast cancer) has recently gained increasing attention. However, based on the expanding role of personalized medicine, clinicians are now faced with substantial new challenges and possibly unsuspected possibilities. The following review summarizes current developments in genetic and genomic testing in luminal MBC.

 

Key messages: In luminal MBC genomics have become an integral component within the spectrum of oncological treatment establishing novel therapeutic facilities. Further developments in treatment personalization adjusted according to the molecular subtype should become increasingly important in order to enhance the progress of de-escalation of chemotherapy in luminal MBC. However, based on the expanding role of personalized medicine, clinicians are now faced with substantial new challenges and possibly unsuspected possibilities.

HIV-P24 antigen array kit

VArk-Lsx001 unit Ask for price
Description: Fourth-generation HIV immunoassays detect viral p24 protein in the blood.

Human HIV-1 And HIV-2 Antibodies Plus P24 Antigen Fourth-Generation ELISA Kit

abx257575-05mg 0.5 mg Ask for price

Human HIV-1 And HIV-2 Antibodies Plus P24 Antigen Fourth-Generation ELISA Kit

abx257575-100g 100 µg
EUR 468.75

Human HIV-1 And HIV-2 Antibodies Plus P24 Antigen Fourth-Generation ELISA Kit

abx257575-1mg 1 mg Ask for price

HIV-1 p17-p24 recombinant antigen.

00172-V 1 MG
EUR 850

HIV-1 p17-p24 recombinant antigen.

00172-V-100ugvial 100ug/vial
EUR 150
Description: HIV-1 p17-p24 recombinant antigen.

HIV-1 GAG P24 Recombinant Antigen

00111-V-01mg 0,1 mg
EUR 321
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa

HIV-1 GAG P24 Recombinant Antigen

00111-V-1000ug 1000 ug
EUR 1539
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa

HIV 1 p24 core recombinant antigen.

00177-V 1 MG
EUR 850

HIV 1 p24 core recombinant antigen

00177-V-01mg 0,1 mg
EUR 321
Description: HIV 1 p24 core recombinant antigen.

HIV 1 p24 core recombinant antigen

00177-V-1000ug 1000 ug
EUR 1539
Description: HIV 1 p24 core recombinant antigen.

HIV 1 p24 core recombinant antigen.

00177-V-100ugvial 100ug/vial
EUR 150
Description: HIV 1 p24 core recombinant antigen.

HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations)

0801200 5 X 96T
EUR 2563

HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations)

801200 5 X 96 Determinations
EUR 2563

HIV Type 1 p24 Antigen ELISA 2.0 (5 X 96 Determinations)

0801008 5 X 96T
EUR 2505

Human HIV(1+2 antibodies plus p24 antigen (4th Generation) ELISA Kit

EH4101 96T
EUR 571.5
Description: Method of detection: Qualitative ;Reacts with: Homo sapiens;Sensitivity: Qualitative

Mouse Anti Human Immunodeficiency Virus (HIV-1) p24 (1947)

MAB12321-100 0.1
EUR 275.56
Description: Mouse monoclonal antibody specific for HIV-1 p24

Mouse Anti Human Immunodeficiency Virus (HIV-1) p24 (1947)

MAB12321-500 0.5
EUR 671.04
Description: Mouse monoclonal antibody specific for HIV-1 p24

Human HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit

NSL1389Hu 96 wells
EUR 468

Human Immunodeficiency Virus p24 Protein [HIV-1/Clade B]

REC31743-100 0.1
EUR 496.27
Description: Recombinant HIV p24 protein (NCBI accession number ABO61536, AA35-265, L40I) produced in HEK293 cells. Protein carries a C-terminal His-tag.. Protein was purified by immobilised metal affinity and ion exchange chromatography from the pellet of transfected cells.

Human Immunodeficiency Virus p24 Protein [HIV-1/Clade B]

REC31743-500 0.5
EUR 1363.78
Description: Recombinant HIV p24 protein (NCBI accession number ABO61536, AA35-265, L40I) produced in HEK293 cells. Protein carries a C-terminal His-tag.. Protein was purified by immobilised metal affinity and ion exchange chromatography from the pellet of transfected cells.

HIV-1 p24 ELISA Kit

Z7040001 1 kit
EUR 865

Bovine HIV-1 p24 core protein(HIV-1 p24) Anti-body ELISA Kit

NSL1181Bo 96 T
EUR 528

OPEF01414-1MG - Recombinant Human Immunodeficiency Virus 1 (HIV 1-p24) Antigen

OPEF01414-1MG 1mg
EUR 2216

Human HIV (1+2) antigen&antibody ELISA Kit

EK11777 96Т
EUR 799

Human HIV (1+2) antigen&antibody ELISA Kit

AE62582HU-48Tests 48 Tests
EUR 360
Description: Human (Homo sapiens)

Human HIV (1+2) antigen&antibody ELISA Kit

AE62582HU-96Tests 96 Tests
EUR 680
Description: Human (Homo sapiens)

HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa

00111-V 1 MG
EUR 850

HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa

00111-V-100ugvial 100ug/vial
EUR 150
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa

HIV-1 p17/24/gp120 antigen

00169-V-01mg 0,1 mg
EUR 321
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120.

HIV-1 p17/24/gp120 antigen

00169-V-1000ug 1000 ug
EUR 1539
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120.

HIV-1 nef antigen

GWB-633F8F 0.5 mg Ask for price

Astrovirus Antigen (Type 1)

AS02-1000 1.0
EUR 1654.65
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells.

Astrovirus Antigen (Type 1)

AS02-200 0.2
EUR 442.69
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells.

Canine Adenovirus 1 Antigen

NAT41587-100 0.1
EUR 391.66
Description: Canine Adenovirus Type 1, produced in A-72 cells.

HIV-1 intergase antigen

00199-V-01mg 0,1 mg
EUR 321
Description: HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase).

HIV-1 intergase antigen

00199-V-1000ug 1000 ug
EUR 1539
Description: HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase).

Herpes Simplex Virus 1 Antigen

HS105-1000 1.0
EUR 1178.79
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation.

Herpes Simplex Virus 1 Antigen

HS105-200 0.2
EUR 294.7
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation.

HIV-1 p24 (HIV-1)

GWB-420F7B 0.1 mg Ask for price

HIV-1 p24 Antibody

20-abx137062
  • Ask for price
  • Ask for price
  • 0.5 mg
  • 1 mg

HIV-1 p24 Antibody

abx023925-1mg 1 mg
EUR 828

HIV-1 p24 Antibody

abx023926-1mg 1 mg
EUR 828

HIV-1 p24 Antibody

abx021869-1mg 1 mg
EUR 794.4

HIV-1 p24 Antibody

abx021870-1mg 1 mg
EUR 760.8

HIV-1 p24 Antibody

abx021871-1mg 1 mg
EUR 794.4

HIV-1 p24 Antibody

abx021872-1mg 1 mg
EUR 794.4

HIV-1 p24 Antibody

abx021873-1mg 1 mg
EUR 794.4

HIV-1 p24 Antibody

abx021882-1mg 1 mg
EUR 1178.4

HIV-1 p24 Antibody

abx021883-1mg 1 mg
EUR 1220.4

HIV-1 p24 Antibody

abx021886-1mg 1 mg
EUR 1220.4

HIV-1 p24 Antibody

abx021887-1mg 1 mg
EUR 1220.4

HIV-1 p24 Antibody

abx021888-1mg 1 mg
EUR 1220.4

HIV-1 p24 Antibody

abx023027-1ml 1 ml
EUR 693.6

HIV-1 p24 Antibody

7313-002mg 0.02 mg
EUR 206.18
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains.

HIV-1 p24 Antibody

7313-01mg 0.1 mg
EUR 523.7
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains.

HIV-1 p24, Antibody

GWB-3B2FFB 1 mg Ask for price

HIV-1 p24 Antibody

GWB-26647C 0.1 mg Ask for price

HIV-1 p24, Antibody

GWB-2D04FA 0.1 mg Ask for price

HIV-1 p24, Antibody

GWB-2DD7E0 0.1 mg Ask for price

HIV-1 p24, Antibody

GWB-192382 0.1 mg Ask for price

HIV-1 p24 Antibody

GWB-846CEC 1 ml Ask for price

HIV-1 p24, Antibody

GWB-9C0291 0.1 mg Ask for price

HIV-1 p24 Antibody

GWB-9EAC4B 1 ml Ask for price

HIV-1 p24 Antibody

GWB-4CB110 1 ml Ask for price

HIV-1 p24 Antibody

GWB-76A9C7 0.1 mg Ask for price

HIV-1 p24 Antibody

GWB-F48F6D 0.1 mg Ask for price

HIV-1 p24, Antibody

GWB-B0158C 0.1 mg Ask for price

HIV-1 p24 Antibody

GWB-BBDE10 1 ml Ask for price

HIV-1 p24 Antibody

GWB-F1D71D 0.1 mg Ask for price

HIV-1 p24 Antibody

abx021869-400l 400 µl Ask for price

HIV-1 p24 Antibody

abx021869-80l 80 µl
EUR 937.5

HIV-1 p24 Antibody

abx021871-400l 400 µl Ask for price

HIV-1 p24 Antibody

abx021871-80l 80 µl
EUR 937.5

HIV-1 p24 Antibody

abx021872-400l 400 µl Ask for price

HIV-1 p24 Antibody

abx021872-80l 80 µl
EUR 937.5

HIV-1 p24 Antibody

abx021873-400l 400 µl Ask for price

HIV-1 p24 Antibody

abx021873-80l 80 µl
EUR 937.5

HIV-1 p24 Antibody

abx021882-400l 400 µl Ask for price

HIV-1 p24 Antibody

abx021882-80l 80 µl
EUR 1237.5

HIV-1 p24 Antibody

abx021883-400l 400 µl Ask for price

HIV-1 p24 Antibody

abx021883-80l 80 µl
EUR 1237.5

HIV-1 p24 Antibody

abx021886-400l 400 µl Ask for price

HIV-1 p24 Antibody

abx021886-80l 80 µl
EUR 1237.5

HIV-1 p24 Antibody

abx021887-400l 400 µl Ask for price

HIV-1 p24 Antibody

abx021887-80l 80 µl
EUR 1587.5

HIV-1 p24 Antibody

abx021888-400l 400 µl Ask for price

HIV-1 p24 Antibody

abx021888-80l 80 µl
EUR 1237.5

HIV-1 p24 Antibody

abx023027-400l 400 µl Ask for price

HIV-1 p24 Antibody

abx023027-80l 80 µl
EUR 1012.5

Canine Adenovirus 1 and 2 Antigen

NAT41589-100 0.1
EUR 391.66
Description: A mixture of Canine Adenovirus Type 1 and Type 2, produced in A-72 cells.

Herpes Simplex Virus 1 Lysate Antigen

HS104-1000 1.0
EUR 270.46
Description: A high concentration of HSV-1 particles and proteins from a clarified cell lysate.

HIV-1 p24

E62H002 100ug
EUR 255

HIV-1 p24

E5-00024 1mg
EUR 700

HIV-1 p24

ant-152 0.5mg
EUR 275
Description: Mouse Anti HIV-1 p24

HIV-1 p24

GWB-3A5505 0.1 mg Ask for price

HIV-1 p24

hiv-006 100µg
EUR 130
Description: Recombinant HIV-1 p24

HIV-1 p24

GWB-1A0810 1 mg Ask for price

HIV-1 p24

GWB-B96BB9 1 mg Ask for price

Leptospira Biflexa Antigen (Strain Patoc 1)

NAT41582-100 0.1
EUR 391.66
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture.

Leptospira Biflexa Antigen (Strain Patoc 1)

NAT41582-500 0.5
EUR 1176.24
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture.

Mouse Anti Human Immunodeficiency Virus (HIV-1) p17 (1981)

MAB12320-100 0.1
EUR 310.01
Description: Mouse monoclonal antibody specific for HIV-1 p17

Mouse Anti Human Immunodeficiency Virus (HIV-1) p17 (1981)

MAB12320-500 0.5
EUR 770.55
Description: Mouse monoclonal antibody specific for HIV-1 p17

p24 (HIV-1)

GWB-549FE4 0.5 ml Ask for price

HIV-1 gag recombinant antigen

8934 100 ug
EUR 542.86
Description: This is HIV-1 gag recombinant antigen for ELISA,WB.

HIV-1 nef recombinant antigen

8941 100 ug
EUR 477.6
Description: This is HIV-1 nef recombinant antigen for ELISA,WB.

HIV-1 tat recombinant antigen

00110-V-01mg 0,1 mg
EUR 321
Description: HIV-1 tat recombinant antigen full length 15 kDa

HIV-1 tat recombinant antigen

00110-V-1000ug 1000 ug
EUR 1539
Description: HIV-1 tat recombinant antigen full length 15 kDa

HIV-1 nef recombinant antigen

00112-V-01mg 0,1 mg
EUR 321
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa

HIV-1 nef recombinant antigen

00112-V-1000ug 1000 ug
EUR 1539
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa

HIV-1 gp41 recombinant antigen

9000 100 ug
EUR 484.13
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB.

HIV-1 gp41 recombinant antigen

9001 100 ug
EUR 484.13
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB.

HIV-1 gp41 recombinant antigen

8908 100 ug
EUR 673.36
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB.

HIV-1 gp41 recombinant antigen

8933 100 ug
EUR 477.6
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB.

HIV-1 gp41 recombinant antigen.

00170-V 1 MG
EUR 850

HIV-1 gp41 recombinant antigen,

00170-V-01mg 0,1 mg
EUR 321
Description: HIV-1 gp41 recombinant antigen.

HIV-1 gp41 recombinant antigen,

00170-V-1000ug 1000 ug
EUR 1539
Description: HIV-1 gp41 recombinant antigen.

HIV-1 gp41 recombinant antigen.

00170-V-100ugvial 100ug/vial
EUR 150
Description: HIV-1 gp41 recombinant antigen.

Borrelia Afzelii Antigen

NAT41583-100 0.1
EUR 391.66
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside.

Borrelia Afzelii Antigen

NAT41583-500 0.5
EUR 1176.24
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside.

Borrelia Garinii Antigen

NAT41584-100 0.1
EUR 391.66
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside.

Borrelia Garinii Antigen

NAT41584-500 0.5
EUR 1176.24
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside.

Brucella Abortus Antigen

NAT41599-100 0.1
EUR 391.66
Description: Brucella abortus lysate, produced by fermentation.

Brucella Abortus Antigen

NAT41599-500 0.5
EUR 1176.24
Description: Brucella abortus lysate, produced by fermentation.

Candida Albicans Antigen

NAT41601-100 0.1
EUR 391.66
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components.

Candida Albicans Antigen

NAT41601-500 0.5
EUR 1176.24
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components.

HIV-1 Antibody (p24)

GWB-44F330 0.1 mg Ask for price

HIV-1 Antibody (p24)

GWB-Q00547 1 mg Ask for price

HIV-1 Antibody (p24)

GWB-T00244 1 mg Ask for price

HIV-1 Antibody (p24)

GWB-T00398 1 mg Ask for price

HIV-1 Antibody (p24)

GWB-T00747 0.5 mg Ask for price

HIV-1 Antibody (p24)

GWB-CF4E51 1 ml Ask for price

Canine Parvovirus Antigen

NAT41594-100 0.1
EUR 391.66
Description: Canine Parvovirus, produced in CRFK cells.

Canine Coronavirus Antigen

NAT41590-100 0.1
EUR 391.66
Description: Canine Coronavirus produced in A-72 cells.

Feline Calicivirus Antigen

NAT41595-100 0.1
EUR 391.66
Description: Feline Calicivirus produced in FC 3TG cells.

Helicobacter Pylori Antigen

NAT41603-100 0.1
EUR 391.66
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation.

Helicobacter Pylori Antigen

NAT41603-500 0.5
EUR 1176.24
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation.

Campylobacter Jejuni Antigen

NAT41600-100 0.1
EUR 391.66
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE.

Campylobacter Jejuni Antigen

NAT41600-500 0.5
EUR 1176.24
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE.

HIV p24 Antibody

abx021867-1mg 1 mg
EUR 1612.8

HIV p24 Antibody

abx021868-1mg 1 mg
EUR 1612.8

HIV p24 Antibody

GWB-3F4E8C 1 mg Ask for price

HIV p24 Antibody

GWB-82D06B 1 mg Ask for price

HIV p24 Antibody

GWB-83EEA8 1 mg Ask for price

HIV p24 Antibody

GWB-A348DD 1 mg Ask for price

HIV p24 Antibody

GWB-A9F8C7 1 mg Ask for price

HIV p24 Antibody

GWB-FDA891 1 mg Ask for price

HIV p24 Antibody

abx021867-400l 400 µl Ask for price

HIV p24 Antibody

abx021867-80l 80 µl
EUR 937.5

HIV p24 Antibody

abx021868-400l 400 µl Ask for price

HIV p24 Antibody

abx021868-80l 80 µl
EUR 1500

Chlamydia Trachomatis Antigen

CT022-1000 1.0
EUR 378.9
Description: Chlamydia trachomatis antigens from clarified cell lysate.

Neisseria Gonorrhoeae Antigen

NG01-1000 1.0
EUR 378.9
Description: Homogenised lysate of pure bacteria.

Mycoplasma Pneumoniae Antigen

MP901-1000 1.0
EUR 1010.39
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background.

Mycoplasma Pneumoniae Antigen

MP901-200 0.2
EUR 270.46
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background.

Echovirus Antigen, Recombinant

REC31776-100 0.1
EUR 276.84
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus

Echovirus Antigen, Recombinant

REC31776-500 0.5
EUR 1043.56
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus

Trichomonas Vaginalis Antigen

TV01-1000 1.0
EUR 421
Description: Washed & lysed suspension of whole protozoa

HIV-1 p24 (HIV-1) recombinant

GWB-FE5FE0 0.1 mg Ask for price

Echinococcus Granulosus Antigen

NAT41602-100 0.1
EUR 391.66
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid.

Echinococcus Granulosus Antigen

NAT41602-500 0.5
EUR 1176.24
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid.

Enterovirus Antigen, Recombinant

REC31772-100 0.1
EUR 276.84
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA.

Enterovirus Antigen, Recombinant

REC31772-500 0.5
EUR 1043.56
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA.

Cytomegalovirus Purified Antigen

CMV-HP-100 0.1
EUR 318.94
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation.

Cytomegalovirus Purified Antigen

CMV-HP-1000 1.0
EUR 2096.06
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation.

Cytomegalovirus Purified Antigen

CMV-HP-500 0.5
EUR 1279.58
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation.

Yersinia pestis V antigen

REC32028-100 0.1
EUR 491.53
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product.

Yersinia pestis V antigen

REC32028-500 0.5
EUR 2421.37
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product.

Canine Herpes Virus Antigen

NAT41592-100 0.1
EUR 391.66
Description: Canine Herpes virus, produced in MDCK cells.

Canine Adenovirus 2 Antigen

NAT41588-100 0.1
EUR 391.66
Description: Canine Adenovirus Type 2, produced in A-72 cells.

HIV-1 p17/24/gp120-gp41 recombinant antigen.

00168-V 1 MG
EUR 850

HIV-1 p17/24/gp120-gp41 recombinant antigen,

00168-V-01mg 0,1 mg
EUR 321
Description: HIV-1 p17/24/gp120-gp41 recombinant antigen.

HIV-1 p17/24/gp120-gp41 recombinant antigen,

00168-V-1000ug 1000 ug
EUR 1539
Description: HIV-1 p17/24/gp120-gp41 recombinant antigen.

HIV-1 p17/24/gp120-gp41 recombinant antigen.

00168-V-100ugvial 100ug/vial
EUR 150
Description: HIV-1 p17/24/gp120-gp41 recombinant antigen.

HTLV-I p24 Antigen

GWB-DF0617 1 mg Ask for price

HIV-1 p24 Antibody (HRP)

abx023029-1ml 1 ml
EUR 886.8

HIV-1 p24 Antibody [8G9]

PM-6335-002mg 0.02 mg
EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [8G9]

PM-6335-01mg 0.1 mg
EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4]

PM-6585-002mg 0.02 mg
EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4]

PM-6585-01mg 0.1 mg
EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody (HRP)

abx023029-400l 400 µl Ask for price

HIV-1 p24 Antibody (HRP)

abx023029-80l 80 µl
EUR 1150

Canine Distemper Virus Antigen

NAT41591-100 0.1
EUR 391.66
Description: Canine Distemper virus, produced in SL-29 cells.

HIV 1 envelope recombinant antigen

00176-V-01mg 0,1 mg
EUR 321
Description: HIV 1 envelope recombinant antigen. HIV-1 evnelope protein spanning the C-Terminus of gp 120 and most of gp 41.

HIV 1 envelope recombinant antigen

00176-V-1000ug 1000 ug
EUR 1539
Description: HIV 1 envelope recombinant antigen. HIV-1 evnelope protein spanning the C-Terminus of gp 120 and most of gp 41.

HIV-1 p24 Antibody (FITC)

abx021884-100ug 100 ug
EUR 886.8

HIV-1 p24 Antibody (FITC)

abx023026-1ml 1 ml
EUR 678

HIV-1 p24 Antibody [10A2]

PM-7371 0.02 mg
EUR 89

HIV-1 p24 Antibody (FITC)

abx021884-400l 400 µl Ask for price

HIV-1 p24 Antibody (FITC)

abx021884-80l 80 µl
EUR 1237.5

 

Related articles

mutationdetection

signatures of positive selection in cytochrome b gene

Trying to find signatures of optimistic choice in cytochrome b gene related to subterranean life-style in fast-evolving arvicolines (Arvicolinae, Cricetidae, Rodentia) Background: Mitochondrial genes encode proteins concerned in oxidative phosphorylation. Variations in life-style and ecological area of interest could be immediately mirrored in metabolic efficiency. Subterranean rodents characterize a very good mannequin for testing hypotheses on adaptive evolution […]

Learn More
mutationdetection

Identification of key gene modules and pathways of human platelet transcriptome

Identification of key gene modules and pathways of human platelet transcriptome in acute myocardial infarction sufferers by way of co-expression community Acute myocardial infarction (AMI) critically threatens human life. On this examine we aimed to systemically analyze the perform of key gene modules in human platelets in AMI. We used weighted gene co-expression community evaluation (WGCNA) […]

Learn More
mutationdetection

putative novel insertion sequence elements in prokaryotic genomes

digIS: in direction of detecting distant and putative novel insertion sequence components in prokaryotic genomes Background: The insertion sequence components (IS components) symbolize the smallest and probably the most plentiful cell components in prokaryotic genomes. It has been proven that they play a big position in genome group and evolution. To higher perceive their perform within the […]

Learn More

Leave a Reply

Your email address will not be published. Required fields are marked *